Outcome of Board Meeting
Declaration of Interim Dividend for the financial year 2017-1812-12-2017
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Rasbihari Trading & Investment Pvt LtdDisclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Kishoriju Trading And Investment Pvt LtdBoard to consider Interim Dividend
Mangalam Drugs & Organics Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on December 12, 2017, inter alia, to consider and declare the interim dividend for the financial year 2017-18.Further, in accordance with Code of Conduct for Prevention of Insider Trading framed by the Company pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015,...Board Meeting On 12Th December, 2017.
This is to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 12th December, 2017 inter-alia, to consider and declare the interim dividend for the financial year 2017-18.Financial Results For September 30, 2017.
Unaudited Financial Results for the quarter and half year ended 30th September, 2017 along with Limited Review Report and the Statement of Assets & Liabilities of the said period in the prescribed form which have been taken on record and approved by the Board of Directors.Outcome of Board Meeting
Intimation of Outcome of Board Meeting dated 20th November, 2017.Board Meeting On November 20, 2017.
In terms of Regulation 29 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Monday, 20th November, 2017 at the registered office of the Company at Mumbai, inter-alia to consider and approve the following: 1. To approve, consider and take on record the Unaudited Financial Results along with Limited review...Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Kishoriju Trading & Investment Pvt Ltd